Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmaceutical Prices Will Increase 6% In 2005, Cardinal Expects

This article was originally published in The Pink Sheet Daily

Executive Summary

Cardinal predicts that prices for pharmaceutical products will increase an average of 6% in 2005

You may also be interested in...



Cardinal Expects More Frequent, But Smaller, Price Increases Through 2005

The transition to a fee-for-service model will prevent Cardinal from taking advantage of the more frequent price increases that are expected in the second half of the year, CEO Walter says. Cardinal expects that 85% of its vendor margins will come from manufacturers under fee-for-service contracts by mid-year.

Cardinal Expects More Frequent, But Smaller, Price Increases Through 2005

The transition to a fee-for-service model will prevent Cardinal from taking advantage of the more frequent price increases that are expected in the second half of the year, CEO Walter says. Cardinal expects that 85% of its vendor margins will come from manufacturers under fee-for-service contracts by mid-year.

Pfizer Price Increases Reassure Cardinal

Pfizer's recent round of price increases is in line with Cardinal's expectations, CEO Robert Walter said Jan. 12 at the J.P. Morgan health care conference in San Francisco

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058368

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel